{"id":"W3137251658","doi":"10.1016/j.ctrv.2021.102187","title":"Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer Foundation; Merck KGaA; EMD Serono; Pfizer","keywords":"Avelumab; Medicine; Metastatic Urothelial Carcinoma; Carboplatin; Chemotherapy; Oncology; Internal medicine; Maintenance therapy; Cisplatin; Clinical trial; Bladder cancer; Javelin; Cancer; Immunotherapy; Nivolumab; Urothelial carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002536892,0.001843084,0.01292216,0.0003515767,0.0001702544,0.0001053566,0.0005318198,0.0006497622,0.001012465],"category_scores_gemma":[0.003676914,0.001128298,0.003697576,0.001511877,0.0001776197,0.0002301837,0.0002133976,0.001275111,0.0006361665],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003417422,"about_ca_system_score_gemma":0.007226739,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004992231,"about_ca_topic_score_gemma":0.0008297652,"domain_scores_codex":[0.9865777,0.002039991,0.006696,0.002732571,0.0007319481,0.001221723],"domain_scores_gemma":[0.9927069,0.002326226,0.001704587,0.001942917,0.000309003,0.001010373],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01652155,0.003503599,0.0001917816,0.00793648,0.001544731,0.002280492,0.00009831563,0.0000019787,4.115535e-8,0.00001002896,0.002888611,0.9650224],"study_design_scores_gemma":[0.07407501,0.008125015,0.00002592496,0.04464017,0.0130892,0.0002965882,0.00003486958,0.000003270869,6.811186e-7,0.000002651353,0.8588973,0.0008093021],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007498491,0.9642329,0.0002101038,0.0006641616,0.003259556,0.03029722,0.0003566024,0.00007684769,0.0008276],"genre_scores_gemma":[0.00001846148,0.9512527,0.007831436,0.0021776,0.002588176,0.03097335,0.0003710716,0.0002717092,0.004515489],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9642131,"threshold_uncertainty_score":0.9999008,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3066253015532885,"score_gpt":0.5286651053873425,"score_spread":0.222039803834054,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}